Publicité
La bourse ferme dans 1 h 26 min
  • CAC 40

    8 027,94
    +4,68 (+0,06 %)
     
  • Euro Stoxx 50

    4 928,77
    -7,80 (-0,16 %)
     
  • Dow Jones

    37 947,28
    +171,90 (+0,46 %)
     
  • EUR/USD

    1,0668
    +0,0022 (+0,20 %)
     
  • Gold future

    2 396,40
    -1,60 (-0,07 %)
     
  • Bitcoin EUR

    60 927,37
    +2 101,42 (+3,57 %)
     
  • CMC Crypto 200

    1 384,32
    +71,69 (+5,78 %)
     
  • Pétrole WTI

    82,75
    +0,02 (+0,02 %)
     
  • DAX

    17 765,66
    -71,74 (-0,40 %)
     
  • FTSE 100

    7 856,31
    -20,74 (-0,26 %)
     
  • Nasdaq

    15 526,58
    -74,92 (-0,48 %)
     
  • S&P 500

    5 009,78
    -1,34 (-0,03 %)
     
  • Nikkei 225

    37 068,35
    -1 011,35 (-2,66 %)
     
  • HANG SENG

    16 224,14
    -161,73 (-0,99 %)
     
  • GBP/USD

    1,2460
    +0,0021 (+0,17 %)
     

GLOBAL NEUROREHABILITATION DEVICE MARKET FORECAST 2021-2028

KEY FINDINGS The global neurorehabilitation device market is expected to grow with a CAGR of 15. 12%, over the forecast period of 2021 to 2028. The market growth is mainly accredited to factors, including the rising elderly population, technological advancements, the significant increase in neurological diseases, and surging neurorehabilitation wearable and robotics.

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLOBAL NEUROREHABILITATION DEVICE MARKET FORECAST 2021-2028" - https://www.reportlinker.com/p05403220/?utm_source=GNW


MARKET INSIGHTS
Neurological rehabilitation, also termed neurorehabilitation, is an essential part of the recovery process of patients who have sustained a brain injury. It aims to facilitate recovery, reduce symptoms, enhance function, and improve patients’ well-being, who have experienced trauma to the nervous system.
The growing incidence of neurological diseases, such as, migraine, Alzheimer’s disease, brain stroke, epilepsy, Parkinson’s, neurodegeneration, and multiple sclerosis, among others, has resulted in the increased adoption of neurological devices for diagnosing and treating them.As per the World Health Organization (WHO), nearly 6 million deaths occur due to strokes, annually.

Likewise, the WHO also states that epilepsy is a common neurological disease, with around 50 million individuals affected, and 2.4 million diagnosed with the condition, every year.

REGIONAL INSIGHTS
The global neurorehabilitation device market growth analysis includes the assessment of the Asia Pacific, North America, Europe, and the rest of the world.North America is anticipated to dominate the global market.

Its growth is supplemented by the increasing elderly population, thereby creating an increased incidence of Alzheimer’s and Parkinson’s disease, federal government funding, and the rising investments for diagnosing and preventing neurogenerative conditions.

COMPETITIVE INSIGHTS
The intensity of competitive rivalry across the global neurorehabilitation market is projected to remain high over the forecast years.Moreover, the market is highly consolidated.

Some of the key players operating in the market include, Medtronic PLC, Abbott Laboratories, Ekso Bionics Holdings, Hocoma AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. ABBOTT LABORATORIES
2. BIOMETRICS LTD
3. BIONIK LABORATORIES CORP
4. BIOXTREME
5. ECTRON LIMITED
6. EKSO BIONICS HOLDINGS INC
7. HELIUS MEDICAL TECHNOLOGIES
8. HOCOMA AG
9. KINESTICA
10. KINOVA
11. MEDTRONIC INC
12. NEUROSTYLE PTE LTD
13. TYROMOTION GMBH
Read the full report: https://www.reportlinker.com/p05403220/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001